Jaguar Health (JAGX) Finished Goods (2018 - 2026)
Jaguar Health (JAGX) posted quarterly Finished Goods of $856000.0 for Q1 2026, down 9.8% year-over-year from $949000.0 in Q1 2025, and down 35.25% quarter-over-quarter from $1.3 million in Q4 2025.
Jaguar Health (JAGX) Finished Goods (2018 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Finished Goods for 9 consecutive years, with $856000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Finished Goods fell 9.8% year-over-year to $856000.0; the TTM figure through Mar 2026 stood at $856000.0 (down 9.8% YoY), while the FY2025 annual figure was $1.3 million, up 21.51% from the prior year.
- Finished Goods retreated to $856000.0 in Q1 2026 per JAGX's latest filing, from $1.3 million in the prior quarter.
- Across five years, Finished Goods topped out at $1.7 million in Q2 2022 and bottomed at $615000.0 in Q4 2023.
- Historically, Finished Goods has averaged $1.0 million across 5 years, with a median of $949000.0 in 2025.
- Annual changes were most pronounced in 2023 — Finished Goods tumbled 53.55% — and 2024, when it soared 76.91%.
- Jaguar Health's Finished Goods stood at $1.3 million in 2022, then sank by 53.55% to $615000.0 in 2023, then jumped by 76.91% to $1.1 million in 2024, then advanced by 21.51% to $1.3 million in 2025, then sank by 35.25% to $856000.0 in 2026.
- Business Quant data shows JAGX's Finished Goods at $856000.0 in Q1 2026, $1.3 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Jaguar Health | 459,102.90 | -9.60 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 856,000.00 |
| Dec 31, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 949,000.00 |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | 765,000.00 |
| Jun 30, 2024 | 768,000.00 |
| Mar 31, 2024 | 692,000.00 |
| Dec 31, 2023 | 615,000.00 |
| Sep 30, 2023 | 798,000.00 |
| Jun 30, 2023 | 868,000.00 |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 895,000.00 |
| Dec 31, 2021 | 892,000.00 |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 990,000.00 |